Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.940
-0.250 (-4.82%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $267.18 million as of March 27, 2026. Its market cap has increased by 80.76% in one year.
Market Cap
267.18M
Enterprise Value
72.65M
1-Year Change
80.76%
Ranking
Category
Stock Price
$4.94
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $267.18M, an increase of 54.29%. That is a compound annual growth rate of 7.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 267.18M | -6.46% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 286.14M |
| AC Immune | 274.79M |
| ALX Oncology Holdings | 268.48M |
| Minerva Neurosciences | 267.44M |
| Foghorn Therapeutics | 264.15M |
| LENZ Therapeutics | 263.38M |
| Anavex Life Sciences | 261.33M |
| Tenax Therapeutics | 256.24M |